Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng Yuan

Showing results (1071-1080 of 1,446) with videos related to

Pageof 145
Sort By:
Hepatology (Baltimore, Md.)|July 19, 2012
Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer systemChia-Yang Hsu, Yun-Hsuan Lee, Cheng-Yuan Hsia, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|June 6, 2020
Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in TaiwanPin-Nan Cheng, Chi-Yi Chen, Ming-Lung Yu, et al.
Canadian Journal of Gastroenterology & Hepatology|July 15, 2022
Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis CSheng-Hung Chen, Hsueh-Chou Lai, Wen-Pang Su, et al.
Scientific Reports|March 5, 2020
Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinomaShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Gastrointestinal Oncology|May 20, 2021
ALBI grade in dialysis patients with hepatocellular carcinoma: prognostic impact and staging strategyShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
BMC Gastroenterology|April 29, 2019
Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agentsWei-Fan Hsu, Hsueh-Chou Lai, Wen-Pang Su, et al.
The Journal of Infectious Diseases|May 10, 2018
Incidence and Predictors of HBsAg Loss After Peginterferon Therapy in HBeAg-Negative Chronic Hepatitis B: A Multicenter, Long-term Follow-up StudyI-Cheng Lee, Sien-Sing Yang, Chieh-Ju Lee, et al.
Scientific Reports|April 13, 2018
Publisher Correction: New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitisHung-Wei Wang, Cheng-Yuan Peng, Hsueh-Chou Lai, et al.
Archives of Surgery (Chicago, Ill. : 1960)|October 19, 2011
The effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: a propensity score matching analysisChien-Wei Su, Hao-Jan Lei, Gar-Yang Chau, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 24, 2009
Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinomaTeh-Ia Huo, Chia-Yang Hsu, Yi-Hsiang Huang, et al.
Pageof 145

Showing results (1071-1080 of 1,446) with videos related to

Sort By:
Pageof 145
Hepatology (Baltimore, Md.)|July 19, 2012
Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer systemChia-Yang Hsu, Yun-Hsuan Lee, Cheng-Yuan Hsia, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|June 6, 2020
Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in TaiwanPin-Nan Cheng, Chi-Yi Chen, Ming-Lung Yu, et al.
Canadian Journal of Gastroenterology & Hepatology|July 15, 2022
Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis CSheng-Hung Chen, Hsueh-Chou Lai, Wen-Pang Su, et al.
Scientific Reports|March 5, 2020
Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinomaShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Gastrointestinal Oncology|May 20, 2021
ALBI grade in dialysis patients with hepatocellular carcinoma: prognostic impact and staging strategyShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
BMC Gastroenterology|April 29, 2019
Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agentsWei-Fan Hsu, Hsueh-Chou Lai, Wen-Pang Su, et al.
The Journal of Infectious Diseases|May 10, 2018
Incidence and Predictors of HBsAg Loss After Peginterferon Therapy in HBeAg-Negative Chronic Hepatitis B: A Multicenter, Long-term Follow-up StudyI-Cheng Lee, Sien-Sing Yang, Chieh-Ju Lee, et al.
Scientific Reports|April 13, 2018
Publisher Correction: New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitisHung-Wei Wang, Cheng-Yuan Peng, Hsueh-Chou Lai, et al.
Archives of Surgery (Chicago, Ill. : 1960)|October 19, 2011
The effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: a propensity score matching analysisChien-Wei Su, Hao-Jan Lei, Gar-Yang Chau, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 24, 2009
Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinomaTeh-Ia Huo, Chia-Yang Hsu, Yi-Hsiang Huang, et al.
Pageof 145